Mark McKechnie - May 14, 2025 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Role
Chief Financial Officer and Treasurer
Signature
/s/ Mark McKechnie
Stock symbol
ACMR
Transactions as of
May 14, 2025
Transactions value $
-$294,300
Form type
4
Date filed
5/16/2025, 04:30 PM
Previous filing
Mar 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McKechnie Mark Chief Financial Officer and Treasurer C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT /s/ Mark McKechnie 2025-05-16 0001775007

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $84K +15K +1666.67% $5.60 15.9K May 14, 2025 Direct
transaction ACMR Class A Common Stock Sale -$378K -15K -94.34% $25.22 900 May 14, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -15K -100% $0.00 0 May 14, 2025 Class A Common Stock 15K $5.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.02 to $25.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The option is fully vested and exercisable.

Remarks:

Chief Financial Officer and Treasurer